Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in ...
Shares of Voyager Therapeutics (NASDAQ:VYGR) plummeted 20% as the company announced a shift in its gene therapy program for ...
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a study suggests. Similar studies have shown that ...
Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...
The Global Amyotrophic Lateral Sclerosis Treatment Market was valued at USD 634 Million in 2023 and expected to grow USD 1021 Million in 2032. Sporadic ALS Holds The Largest Market Share In The Type ...
Company to assess alternate payloads; no changes planned to novel capsid component - - Resulting shift of timeline and costs extends cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback